Potential impact of the hypomethylating agent 5-azacitidine on chronic lymphocytic leukemia with del(17)(p)/del(p53) and subsequent therapy-related acute myeloid leukemia without these aberrations: a case report
2015 ◽
Vol 8
(2)
◽
pp. 144-147
◽
2000 ◽
Vol 42
(2)
◽
pp. 114-117
◽
2011 ◽
Vol 52
(5)
◽
pp. 754-763
◽
1989 ◽
Vol 30
(3)
◽
pp. 174-180
◽
2010 ◽
Vol 51
(11)
◽
pp. 2120-2125
◽
2011 ◽
Vol 65
(5)
◽
pp. 319-321
◽